Investigation of optimal anticoagulation strategy for stroke prevention in Japanese patients with atrial fibrillation-The J-RHYTHM Registry study design

被引:64
作者
Atarashi, Hirotsugu [1 ]
Inoue, Hiroshi [2 ]
Okumura, Ken [3 ]
Yamashita, Takeshi [4 ]
Origasa, Hideki [5 ]
机构
[1] Tama Nagayama Hosp, Nippon Med Sch, Dept Internal Med, Tokyo, Japan
[2] Toyama Univ, Grad Sch Med, Dept Internal Med 2, Toyama 930, Japan
[3] Hirosaki Univ, Grad Sch Med, Aomori, Japan
[4] Cardiovasc Inst, Tokyo, Japan
[5] Toyama Univ, Grad Sch Med, Div Biostat & Clin Epidemiol, Toyama 930, Japan
关键词
Anticoagulants; Atrial fibrillation; Stroke; Thromboembolism; OPTIMAL INTENSITY; WARFARIN THERAPY; INTRACRANIAL HEMORRHAGE; SECONDARY PREVENTION; RISK-FACTORS;
D O I
10.1016/j.jjcc.2010.09.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: In order to prevent stroke in atrial fibrillation (AF) lower international normalized ratios (INR) (1.6-2.6) were recommended for elderly Japanese patients, but only one clinical study supported this recommendation. Methods and results: The J-RHYTHM Registry is a large, contemporary, prospective observational investigation, with a 2-year follow-up, of patients with AF. Over 6000 AF patients of all types under clinical observation at approximately 150 sites in 10 geographical regions that together cover the whole of Japan will be enrolled in numbers proportional to the population densities of those areas. The primary endpoints of the study will be symptomatic stroke including transient ischemic attack, systemic thromboembolism, and major bleeding including intracranial hemorrhage requiring hospitalization. At each visit, the accumulated demographic data and INR will be examined to determine the appropriate INR for Japanese AF patients. Conclusions: The study will offer a contemporary overview of the anticoagulation status throughout Japan, and will follow more than 6000 patients spread throughout the country for 2 years, to obtain important information, including the optimal INR for Japanese AF patients (UMIN Clinical Trials Registry UMIN000001569). (C) 2011 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:95 / 99
页数:5
相关论文
共 15 条
[1]  
[Anonymous], 2008, CIRC J S4
[2]   Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].
Chobanian, AV ;
Bakris, GL ;
Black, HR ;
Cushman, WC ;
Green, LA ;
Izzo, JL ;
Jones, DW ;
Materson, BJ ;
Oparil, S ;
Wright, JT ;
Roccella, EJ .
HYPERTENSION, 2003, 42 (06) :1206-1252
[3]   ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society [J].
Fuster, Valentin ;
Ryden, Lars E. ;
Cannom, David S. ;
Crijns, Harry J. ;
Curtis, Anne B. ;
Ellenbogen, Kenneth A. ;
Halperin, Jonathan L. ;
Le Heuzey, Jean-Yves ;
Kay, G. Neal ;
Lowe, James E. ;
Olsson, S. Bertil ;
Prystowsky, Eric N. ;
Tamargo, Juan Luis ;
Wann, Samuel .
CIRCULATION, 2006, 114 (07) :E257-E354
[4]   Validation of clinical classification schemes for predicting stroke - Results from the national registry of Atrial Fibrillation [J].
Gage, BF ;
Waterman, AD ;
Shannon, W ;
Boechler, M ;
Rich, MW ;
Radford, MJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (22) :2864-2870
[5]   RISK-FACTORS FAR INTRACRANIAL HEMORRHAGE IN OUTPATIENTS TAKING WARFARIN [J].
HYLEK, EM ;
SINGER, DE .
ANNALS OF INTERNAL MEDICINE, 1994, 120 (11) :897-902
[6]   Risk factors for thromboembolism in patients with paroxysmal atrial fibrillation [J].
Inoue, H ;
Atarashi, H .
AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (08) :852-855
[7]   Ethnic differences in cardiovascular drug response potential contribution of pharmacogenetics [J].
Johnson, Julie A. .
CIRCULATION, 2008, 118 (13) :1383-1393
[8]  
Kuzuya Takeshi, 1999, Journal of the Japan Diabetes Society, V42, P385
[9]  
LEE E.T., 1992, Statistical Methods for Survival Data Analysis
[10]  
ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236